Entity Wide Disclosures (Tables)

3 Months Ended

Mar. 31, 2019

Entity Wide Disclosures [Abstract]

Summary of Revenue by Major Source

The following table disaggregates our revenue by major source (in thousands):

	Three Months Ended March 31, 2019		Three Months Ended March 31, 2018
Therapeutic Area
Oncology	$	55,962	$	43,853
Other		51,319		34,217
Metabolic		33,742		28,513
Cardiology		20,424		23,736
AVAI		19,924		16,679
Central Nervous System		14,868		13,165
Medical Devices		4,502		2,914
Total revenue	$	200,741	$	163,077